The subcellular localization of hepatobiliary transport proteins directly affects the rate of bile formation, e.g., the conjugate export pump multidrug resistance protein 2 (MRP2) is regulated on a short-term scale by retrieval from and insertion into the canalicular membrane in the liver. This study reports on the effects of protein kinase C on MRP2 localization and activity in human hepatoblastoma 
The subcellular localization of hepatobiliary transport proteins directly affects the rate of bile formation, e.g., the conjugate export pump multidrug resistance protein 2 (MRP2) is regulated on a short-term scale by retrieval from and insertion into the canalicular membrane in the liver. This study reports on the effects of protein kinase C on MRP2 localization and activity in human hepatoblastoma The multidrug resistance protein 2 (MRP2) is localized at the apical membrane of liver parenchymal cells and mediates the canalicular secretion of glutathione and glucuronide conjugates. [1] [2] [3] [4] Defective expression of MRP2 underlies the jaundice in the human Dubin-Johnson syndrome. 5 In different cell lines MRP2 confers resistance to cytotoxic drugs such as cisplatin and doxorubicin. 6, 7 In rat liver, Mrp2 as well as other canalicular ATP-binding cassette (ABC) transporters such as the bile salt export pump (Bsep/Spgp) are regulated on a longterm scale on the level of expression by endotoxin, 8 bile duct ligation, 9,10 osmolarity, 11, 12 dexamethasone, 11 or drugs. 13 On a short-term scale, these transporters are regulated by transporter retrieval from and insertion into the canalicular membrane, in response to anisoosmolarity, 14, 15 endotoxin, 8, 15 phalloidin 16 or oxidative stress. 17 Cyclic adenosine monophosphate was shown to stimulate Mrp2 insertion into the canalicular membrane of isolated rat hepatocytes. 18 Besides cyclic adenosine monophosphate and protein kinase A, other signal transduction cascades are known to be involved in bile formation. MAP kinases mediate the short-term effects of cell swelling 19 and tauroursodeoxycholate, 20, 21 and different protein kinase C (PKC) isoforms have inhibitory or stimulatory effects on bile formation. [22] [23] [24] [25] It was reported that stimulation of the PKC␣ isoform by tauroursodeoxycholate increased 24 whereas stimulation of the PKC isoform by taurolithocholate decreased bile flow. 25 Therefore it can be speculated that the balance between different activated PKC isoforms influence the resulting effect on bile flow. Cholestatic effects of PKC activators involve impaired apical exocytosis 26 and reduced sinusoidal bile acid uptake. 27 In human HepG2 hepatoblastoma cells PKC activation reduces the delivery of sphingolipids to the canalicular membrane. 28 Here we show that in HepG2 cells targeting of canalicular transporters to the basolateral membrane occurs in response to PKC stimulation. Similarly, in rat liver Mrp2 partially localizes to the basolateral membrane on phorbol-12-myristate-13-acetate (PMA) stimulation. These changes in transporter localization provide a not yet recognized mechanism that may contribute to cholestasis.
Nonessential amino acids and geniticin were from Gibco BRL (Karlsruhe, Germany), type IV collagenase and TRITC-phalloidin were from Sigma (Deisenhofen, Germany). The EAG5 polyclonal antibody was raised in a rabbit against the 12 amino-acid sequence at the carboxyl terminus of the human MRP2 sequence, 29 the EAG15-antibody was raised against the 12 amino-acid sequence of the carboxyl terminus of the rat Mrp2 sequence, 30 both antibodies were a generous donation from Prof. Dr. D. Keppler (DKFZ Heidelberg, Germany). The mouse monoclonal antibodies M2I-4 and M2III-6 were raised against the amino acids 215 to 310 and 238 to 247, respectively, of human MRP2 31 and were a generous gift of Rick J. Scheper (Free University Hospital, Amsterdam, The Netherlands). The monoclonal MRPm6 (mouse anti-human MRP1) was purchased from Alexis (Grü nberg, Germany). 32 The K4 rabbit anti-rat Ntcp antibody was a generous gift of Bruno Stieger and Peter Meier (Kantonsspital, Zü rich, Switzerland). 33 The anti-mouse ZO-1 antibody was from Biozol (Eching, Germany), 34 and the anti-occludin antibody was from Zymed (San Francisco, CA). The anti-human dipeptidylpeptidase (DPP) IV antibody (anti-CD26) was from Dianova (Hamburg, Germany). The mouse monoclonal anti-rat DppIV (MAP 13.4) was a generous gift of Prof. Dr. W. Reutter (Freie University Berlin, Germany). 35 Secondary antibodies directed against rabbit, mouse, or rat were conjugated with fluorescein (FITC) or Cy3 and were raised in goats. They were purchased from Jackson ImmunoResearch Laboratories (West Grove, PA). Sheep anti-rabbit IgG-POD was from Boehringer Mannheim (Mannheim, Germany), and chloromethylfluorescein-diacetate and fluorescein-methotrexate were from Molecular Probes (Eugene, OR). Enhanced chemiluminescence detection kit was purchased from Amersham-Pharmacia (Freiburg, Germany).
Cell Culture. HepG2 cells were cultured in medium containing glucose (4.5 g/L), penicillin (100 U/mL), streptomycin (100 g/mL), nonessential amino acids (80 mg/L), and 10% fetal bovine serum. They were kept in tissue culture flasks (Falcon, Heidelberg, Germany) in a humidified, 5% CO 2 atmosphere at 37°C. Subconfluent HepG2 cells were subcultured and seeded in flasks, in 6-well plates (Falcon) or on glass coverslips (A12 mm) contained in 24-well plates. Subconfluent HepG2 cells were used for the experiments. Transfected HepG2 cells stably expressing the rat sodium-taurocholate cotransporting peptide (Ntcp) coupled with the enhanced green fluorescence protein (EGFP) 36 were cultured as described above in the presence of geniticin.
Preparation of Human Parenchymal Cells. A small piece of human liver tissue, which was surgically removed because of metastatic liver disease, was cannulated with several cannulas and perfused with HEPES buffer (10 mmol/L HEPES, 143 mmol/L NaCl, 7 mmol/L KCl, and 0.2 mmol/L EGTA) at 37°C for 20 minutes. Thereafter it was perfused with type IV collagenase (750 mg/L in a buffer containing 50 mmol/L HEPES, 100 mmol/L NaCl, and 5 mmol/L CaCl 2 ) at 37°C for 30 minutes. The tissue was disrupted and gently shaken, and the cell suspension was centrifuged 3 times with 28g for 3 minutes. In between, the pellet was retained, resuspended in Krebs-Henseleit buffer (KHB) and filtered through a 70-m cell strainer. Cell viability was greater than 90% (trypan blue exclusion). The cells were plated in 6-well plates in a density of 1 ϫ 10 5 cells per cm 2 and cultured for several days as described above.
Western Blot Analysis. For Western blot analysis of the human MRP2, HepG2 or human liver parenchymal cells grown in 6-well plates were lysed in 150 L of a buffer containing 0.5% sodium dodecyl sulfate (SDS), 10 mmol/l Tris-HCl, pH 7.4 supplemented with a cocktail of protease inhibitors (Complete, Boehringer Mannheim, Mannheim, Germany). Protein content of the individual samples was determined in triplicate with the Biorad protein assay (Biorad, Mü nchen, Germany) by the Laury method according to the manufacturer's guidelines. Cell lysates were separated by SDS polyacrylamide gel electrophoresis (PAGE) using 30 g of total protein per lane as described in Kubitz et al. 11 After blotting and blocking, MRP2 was detected by the EAG5 (1:5,000), M2I-4 or M2III-6 antibodies (1:50) and by the use of the enhanced chemiluminescence detection kit.
Rat Liver Perfusion. The experiments were approved by the responsible local authorities. Livers of male Wistar rats (120-150 g) were perfused in situ in a nonrecirculating system with KHB at 37°C, equilibrated with 5%/95% (vol/vol) CO 2 /O 2 and supplemented with 0.3 mmol/L pyruvate and 2.1 mmol/L lactate as described previously. 19 Bile ducts were cannulated and bile samples were collected in 5-minute intervals. Liver viability was assessed from the measurements of portal pressure and lactic dehydrogenase efflux. PMA (100 nmol/L) or dimethyl sulfoxide (DMSO) as control were added to the influent after 15 minutes of perfusion. After 90 minutes of PMA/ DMSO perfusion, a liver lobe was excised and snap frozen in isopentane precooled in liquid nitrogen. Cryosections of the livers (7 m) were performed as described previously. 8, 14 The liver weight was estimated to be 4% of the body weight.
Immunocyto-/histochemistry. For immunocytochemistry cells cultured on glass coverslips or cryosections of livers were fixed with pure methanol (Ϫ20°C, 10 minutes). Unspecific binding was blocked with bovine serum albumin (1% in phosphate-buffered saline, 1 hour). , anti-rat Ntcp (K4 1:200) a single primary antibody or phosphatebuffered saline alone for control staining were applied for 2 hours of incubation in a wet chamber at room temperature or overnight at 4°C. After rinsing and washing, the appropriate secondary antibodies conjugated to Cy3 (1:500) or FITC (1:100) were applied for 2 hours. Finally, the cells/sections were washed and mounted on slides. Nuclear staining was achieved by addition of propidium iodide (5 g/ mL) or DAPI (Vector, Burlingame, CA). To visualize filamentous (F) actin HepG2 cells were fixed with methanol for 45 seconds and thereafter incubated with TRITC-phalloidin (1 g/mL) for 30 minutes.
Confocal Laser Scanning Microscopy. Immunostained cell samples were analyzed using a Leica TCS-NT confocal laser scanning system with an argon-krypton laser on a Leica DM IRB inverted microscope (Bensheim, Germany). Images were acquired from 2 channels at 488 nm (to visualize the enhanced green fluorescent protein attached to the Ntcp or FITC) and 568 nm wavelength (to visualize Cy3 or propidium iodide). Identical settings were used to compare cells or liver sections from different experimental conditions. Crosstalk of fluorochromes was excluded by the use of the acousto optical tunable filter.
Evaluation of MRP2 Function in HepG2 Cells. The secretory activity of MRP2 in cultured HepG2 cells was assessed by the use of 5-chloromethylfluorescein diacetate (CMFDA). The lipophilic compound CMFDA is taken up into the cells by diffusion. It gets fluorescent and hydrophilic (and hence trapped in the cytosol) through the cleavage of the acetate groups by unspecific, cytosolic esterases. Thereafter the compound is conjugated with glutathione by the glutathione-Stransferase. 37 Glutathione-methylfluorescein (GS-MF) was shown to be a substrate of the rat Mrp2. 18 Cultured cells grown on glass coverslips were placed in a bath holder, covered with 200 L KHB at room temperature and mounted on the inverted microscope of the confocal laser scanning system. After adjustment of the optical plane, CMFDA, dissolved in KHB, was added to the bath resulting in a final concentration of 2.5 mol/L CMFDA. Cells in an area of 125 ϫ 125 m were scanned just before addition of CMFDA and thereafter every minute for up to 30 minutes (488 nm exciting light, emission measured at wavelengths Ͼ515 nm) with constant adjustments resulting in a stack of 32 consecutive pictures of the same region. These series were analyzed with PowerPhysiology software (Leica). In the given field of vision pseudocanaliculi (ϭ sites of GS-MF accumulation) were chosen as areas of interest (5 to 20 per field depending on experimental condition). The time-dependent increase in fluorescence was followed in these areas of interest. The background was calculated for each time point from the mean fluorescence intensity measured over all cells and was substracted. All curves of an individual experiment were averaged. 36 ). These cells were stained for MRP2 with the EAG5-antibody (red). The green fluorescence, tracing Ntcp, is predominantly found at the cell membrane, whereas MRP2 is concentrated at the pseudocanaliculi, resembling the transporter distribution of the intact organ. (G) HepG2 cells were stained for MRP2 (red, middle picture) and DPPIV (green, right picture). Colocalization results in yellow (left picture). MRP2 is almost confined to the pseudocanalicular domains (arrows). DPPIV colocalizes with MRP2 at the apical poles (arrows) but was also found at the basolateral membrane of some cells. 
Quantification of MRP2-Positive Canaliculi and Sites of Occludin Accumu-
lation. After the experiments described in the Results, HepG2 cells were fixed and stained. The nuclei of the cells were stained with propidium iodide (red fluorescence) or with DAPI (blue fluorescence), MRP2 and occludin were visualized by the use of the EAG5-antibody or the anti-occludin antibody, respectively, and an FITCconjugated secondary antibody (green fluorescence). Cells were analyzed in a blinded fashion by conventional epifluorescence and using a ϫ40 lens of an Axioskop microscope (Zeiss, Oberkochen, Germany). Nine fields per condition were chosen randomly and the nuclei (50 to 350 nuclei per field) and MRP2-containing pseudocanaliculi (zero to 40 canaliculi per field) or sites of occludin-accumulation forming belt-like structures were counted. The entire depth of the cellular layer was scanned by moving the optical plane between the coverslip and the glass slide, watching the fluorescence with a low-light camera (Intas, Gö ttingen, Germany) mounted on the microscope. The ratios of canaliculi (containing MRP2 or surrounded by occludin) per nuclei were calculated and used for statistical analysis.
Statistics. Data were reproduced in at least 3 independent cell preparations or rat livers. Values are given as means Ϯ standard deviations. The 2-sided Student's t test was used for statistical analysis, with P Ͻ .001 considered to be statistically significant.
RESULTS

Expression of MRP2 in HepG2
Cells. Subconfluent HepG2 cells formed vacuolar-like structures between adjacent cells as seen by light microscopy (Fig. 1A) . Immunocytochemistry showed staining of equivalent structures in HepG2 cells by EAG5, M2I-4, and M2III-6, 3 antibodies directed against different epitopes of the human MRP2 (for EAG5 see In Western blot analysis using SDS-PAGE, the same anti-MRP2 antibodies (EAG5, M2I-4, M2III-6) detected a major band of approximately 190 kd in untransfected HepG2 cells, in HepG2 cells transfected with the vector expressing the EGFP only and in HepG2 cells transfected with the rat sodium/taurocholate cotransporting protein coupled with EGFP (EGFP-Ntcp) and in isolated human liver parenchymal cells. These bands correspond to the known molecular mass of MRP2 (Fig. 2) .
Higher microscopic magnification of HepG2 cells revealed predominant staining of pseudocanalicular structures with some intracellular MRP2 staining (Fig. 1D) . The fluorescence inside the cells most likely represents MRP2 in vesicle-like structures. Costaining of MRP1 and MRP2 by the MRPm6 and EAG5 antibodies, respectively, revealed a distinct distribution of the 2 transporters, which belong to the ABC transporter family. MRP1 (green) was typically localized between adjacent cells, whereas MRP2 (red) was detected in canaliculi-like domains (Fig. 1E) . In HepG2 cells stably transfected with the EGFP-Ntcp a polarized distribution of MRP2 and Ntcp could be shown (Fig. 1F) . Al- though EGFP-Ntcp (green) apparently marked the cell membrane, MRP2 (red) was confined to the apical compartment. The distribution of MRP1, Ntcp, and MRP2 resembles the transporter distribution in the intact organ, where Ntcp is localized in the basolateral/sinusoidal membrane, MRP1 in the lateral membrane, and MRP2 in the apical/ canalicular membrane. Accordingly, DPPIV, another canalicular marker protein, colocalized with MRP2 in the pseudocanaliculi (Fig. 1G, arrows) . Interestingly, some immunoreactive DPPIV was also detected in the basolateral membrane of HepG2 cells and in intracellular vesicle-like structures in close vicinity of the apical pole (Fig. 1G, inset) . The basolateral staining may reflect the indirect targeting described for DPPIV in rat liver cells, 38, 39 where newly synthesized canalicular proteins reach the apical membrane via the basolateral membrane and a transcytotic compartment. Furthermore, it was observed that the intracellular DPPIV-containing vesicle-like structures (green) were free of MRP2 (red, Fig. 1G, inset) .
Costaining of MRP2 (green) and occludin (red) revealed that occludin formed belt-like structures around the MRP2-containing pseudocanaliculi (Fig. 1H) . Costaining of occludin and the zona occludens protein 1 (ZO-1), another protein belonging to the tight junctional complex, showed complete colocalization of these proteins at the pseudocanaliculi (Fig.  1I) . In normal HepG2 cells each pseudocanalicular MRP2-accumulation simultaneously showed bands of occludin. In contrast, some belt-like accumulations of occludin did not show MRP2 immunoreactivity. Taken together these results suggest that formation of the tight-junctional barrier may be a prerequisite for polarized cell growth.
Effects of PMA on the Localization of MRP2. The number of MRP2-positive pseudocanaliculi was far below the number of cells, indicating that only a subpopulation of the HepG2 cells showed apical accumulation of MRP2. The ratio of MRP2-positive pseudocanaliculi per cell nuclei (further termed canalicular index) in untreated cells of all series of this study was 10.8 Ϯ 0.2 % (mean Ϯ SEM, n ϭ 360). Addition of 100 nmol/L of PMA to subconfluent HepG2 cells induced a significant loss of MRP2-positive canaliculi within 1 hour, and a decrease of the canalicular index to 5.3 Ϯ 0.4% compared with 10.1 Ϯ 0.3 % under control conditions (n ϭ 27 from 3 independent cell preparations). This effect was maximal after 4 hours of PMA treatment, with a canalicular index of 0.8 Ϯ 0.1% (Fig. 3A) , reflecting a loss of more than 90% of MRP2-containing pseudocanaliculi. After longer periods of PMA incubation, the canalicular index slowly recovered, reaching control values after approximately 24 to 36 hours (Fig. 3A) . The loss of MRP2-positive pseudocanaliculi was dose dependent, with a half-maximal effect between 0.1 and 1 nmol/L PMA applied for 4 hours (Fig. 3B) . The effect of PMA treatment on the disappearance of MRP2 from the pseudocanaliculi was attributed to PKC activation, because the PKC inhibitor Gö 6850 (1 mol/L) almost completely abolished the PMA effect (Fig. 4A) . PMA is known to activate the MAP kinases Erk1 and Erk2 upstream of MEK via PKC. However, the MEK inhibitor PD098059 (5 mol/L) did not inhibit the effect of PMA on pseudocanalicular MRP2 disappearance ( the concentration of PD098059 used (5 mol/L) was sufficient to block hypo-osmotic Erk activation in primary rat hepatocytes. 21 The disappearance of immunoreactive MRP2 from the pseudocanaliculi was accompanied by a reduced secretory activity as shown by the use of CMFDA and confocal laser scanning microscopy (Fig. 5) . In untreated HepG2 cells a maximal accumulation of GS-MF, the glutathione conjugate of CM-FDA, at pseudocanalicular sites was observed during the first 30 minutes. In HepG2 cells treated with 100 nmol/L of PMA for 4 hours, less sites of fluorescence accumulation were detected. Furthermore the magnitude of fluorescence accumulation at the remaining pseudocanaliculi was strongly reduced with a mean fluorescence intensity of less than 20% compared with control values after 30 minutes of CMFDA incubation.
Interestingly, the disappearance of MRP2 from the pseudocanaliculi of HepG2 cells was accompanied by the appearance of MRP2 at the basolateral membrane (Fig. 6B, PMA nmol/L for 4 hours). The basolateral localization was evidenced by the colocalization of MRP2 with DPPIV (Fig. 6C) , which was shown to stain both the basolateral and apical membrane already under control conditions (Fig. 1G) . Despite the colocalization of MRP2 and DPPIV at the basolateral membrane virtually all of the intracellular DPPIV-containing vesicle-like structures were MRP2 free. In transfected HepG2 cells basolateral localization of MRP2 was likewise shown by the colocalization with Ntcp-EGFP (Fig. 6D) . Colocalization at the lateral membrane was also shown for MRP2 and MRP1 (Fig. 6E) .
The appearance of immunoreactive MRP2 at the basolateral membrane was already observed 30 minutes after the addition of 100 nmol/L of PMA (Fig. 6F), i. e., at a time point when the reduction of the number of MRP2-positive canaliculi had not yet reached statistical significance (see Fig. 3A) . Furthermore, basolateral staining of MRP2 was consistently detectable at PMA concentrations as low as 0.5 nmol/L after 4 hours of incubation, and in 2 of 4 experiments basolateral staining was detectable in some cells at a PMA concentration of 0.1 nmol/L (Fig. 6G) . At this concentration, the reduction of the number of MRP2-positive pseudocanaliculi was not significant (7.1 Ϯ 1.7% at 0.1 nmol/L PMA versus 9.9 Ϯ 1.3% in control cells, mean Ϯ SD, Fig. 3B ).
At high PMA concentrations (Ն10 nmol/L) disruption and complete disappearance of most occludin belts were regularly observed. The number of occludin-positive canalicular domains were reduced similarly to the number of MRP2-positive canaliculi. After 4 hours of PMA treatment (100 nmol/L) the ratio between occludin bands and nuclei was only 0.6 Ϯ 0.1% compared with 6.2 Ϯ 0.5% (mean Ϯ SEM, n ϭ 4) under control conditions. This value is below the canalicular index for MRP2 (10.8 Ϯ 0.9). This discrepancy is explained by differences of sensitivity of conventional and confocal microscopy. Although confocal laser scanning microscopy revealed, that each MRP2-positive canaliculus was delineated by occludin, the reduced sensitivity of conventional epifluorescence in detecting the sparse occludin bands accounts for the lower number of occludin-positive canaliculi compared with MRP2-positive canaliculi. Nevertheless a loss of more than 90% of occludin-bearing canaliculi was observed, suggesting a relationship between apically localized MRP2 and tight-junctional integrity.
Staining with TRITC-phalloidin revealed that F-actin was localized at the basolateral membrane with some enrichment at the apical pole in untreated HepG2 cells (not shown). The actin-depolymerizing agent cytochalasin D (1 mol/L) was applied 30 minutes before and during 4 hours in the presence or absence of PMA (100 nmol/L). It destroyed the F-actin network within 30 minutes but had no effect on the number of MRP2-positive pseudocanaliculi, on the PMA-induced decrease of MRP2-positive canaliculi (Fig. 7A ) and on MRP2-targeting to the basolateral membrane (not shown).
In contrast, disruption of microtubules by colchicine (5 mol/L) led to a significant loss of MRP2-positive pseudocanaliculi (from 9.7 Ϯ 1.2% to 1.9 Ϯ 1.1%, Fig. 7A ) even in the absence of PMA. The colchicine-induced reduction of MRP2-positive pseudocanaliculi was not accompanied by the appearance of basolateral MRP2, but a punctate intracellular MRP2-staining was observed (Fig. 7B ). Colchicine and PMA together did not further increase the loss of MRP2-positive pseudocanaliculi compared with colchicine alone (Fig. 7A) . In a few cells PMA still induced the appearance of MRP2 at the basolateral membrane even in the presence of colchicine (Fig.  7C) .
To exclude the possibility that newly synthesized MRP2 reached the basolateral membrane under the influence of PMA, HepG2 cells were pretreated with cycloheximide, an inhibitor of protein synthesis. Cells were pretreated with cycloheximide (3.5 mol/L) 1 to 4 hours before and during the 4 hours of incubation with PMA (100 nmol/L). Even after 4 hours of cycloheximide preincubation basolateral appearance of MRP2 was observed.
Effects of PMA on the Localization of MRP2 in the Perfused Rat
Liver. Rat livers were perfused with PMA (100 nmol/L) for 90 minutes. The bile flow decreased rapidly after addition of PMA and reached values of 15% compared with control perfusions (Fig. 8A) . Lactic dehydrogenase release into the perfusate was increased 2 to 4 times under the influence of PMA compared with control (Fig. 8B) . In cryosections of control livers Mrp2 was exclusively localized in the canaliculi (Fig.  9A) . In contrast after PMA treatment almost the entire liver showed an additional, strong Mrp2-immunoreactivity in a punctate pattern (Fig. 9B and F) . Most importantly in some selected areas, Mrp2 was found to be localized in the sinusoidal membrane. This was shown by 2 different antibodies: the rabbit anti-rat Mrp2 (EAG15) antibody (Fig. 9B and F) and the mouse anti-human MRP2 (M2III-6), which is known to crossreact with the rat Mrp2 (Fig. 9C) . Sinusoidal localization of Mrp2 was shown by doublestaining with the rabbit anti-rat Ntcp antibody (Fig. 9C) , which detects the basolateral sodium-dependent bile salt transporter. Costaining of Mrp2 and DppIV revealed a colocalization of these 2 proteins in the canaliculi and to some extent a faint staining for both proteins at the basolateral membrane. These results show that small amounts of Mrp2 might be targeted to the sinusoidal/basolateral membrane on PMA stimulation in the intact organ.
DISCUSSION
This study shows on a morphologic and functional level that HepG2 cells express canalicular MRP2 as described by others. 40, 41 HepG2 cells grow in a polarized fashion with a distribution of MRP1 and Ntcp to basolateral and DPPIV and MRP2 to the canalicular membrane. Functional activity of MRP2 was shown by the secretion of its substrates GS-MF 11, 18 and FLMtx 42, 43 into spaces corresponding to the pseudocanaliculi, which were detected by immunocytochemistry. Transporter retrieval from and insertion into the canalicular membrane plays an important role in bile formation. 8, 10, 14, 16, 17, 44 Because HepG2 cells show the polarized localization of MRP2, they were used as a tool to study the regulation of transporterlocalization as a particular aspect of bile secretion and cholestasis on a cellular level.
Liver parenchymal cells and HepG2 cells are believed to target canalicular proteins to the apical (canalicular) pole via the indirect pathway, 38, 39, [45] [46] [47] [48] where newly synthesized proteins destined for the canaliculus first reach the basolateral and then the apical membrane. Such indirect targeting was shown for the rat DppIV 38,39 and the ecto-ATPase. 48 Our results show that in untreated HepG2 cells DPPIV was detectable in the pseudocanalicular domain but also in the basolateral membrane, which may reflect the indirect targeting. Interestingly, no MRP2 was found under normal conditions at the basolateral membrane or in the DPPIV-positive vesiclelike structures that were regularly observed in these cells (Fig.  1G, inset) . These observations suggest that MRP2 and DPPIV may have different kinetics in terms of synthesis rate and targeting to the apical membrane or may have different targeting routes. In line with this in a rat liver canalicular ABCtransporter such as Mdr1, Mdr2 and Bsep are directly targeted to the apical membrane whereas ecto-ATPase (cCAM105) is indirectly targeted. 48 On the other hand, Soroka et al. recently observed a colocalization of Mrp2 and Bsep with the IgAreceptor, a transcytotic marker protein, in tubulin-bound vesicles of isolated rat hepatocytes, 49 suggesting an indirect targeting of these apically delivered proteins.
PKC is known to be involved in the regulation of bile secretion [22] [23] [24] [25] and to regulate sphingolipid transport and polarity in HepG2 cells. 28 Activation of PKC by low concentrations (5-20 nmol/L) of PMA reduced the direct and indirect transport of sphingolipids to the apical pole of HepG2 cells, whereas high concentrations (100 nmol/L) led to a loss of cell polarity. 28 Here we report that PMA treatment of HepG2 cells induces a loss of MRP2 from the canalicular membrane of HepG2 cells by more than 90% and its retargeting to the basolateral membrane. The disappearance of MRP2 is mainly attributable to PKC activation because inhibition of PKCs by Gö 6850 completely abolished the PMA-induced effect on MRP2-dislocation. Gö 6850 blocks the conventional, Ca 2ϩ -dependent PKCisoforms ␣, ␤ 1 , ␤ II , and ␥ and the novel, Ca 2ϩ -independent PKC-isoforms ␦ and at nanomolar concentrations. All these PKC-isoforms are sensitive to PMA. 50 HepG2 cells express at least the PKC-isoforms ␣, ␤, , and . 51, 52 Therefore, it is likely that 1 or more of the 3 Gö 6850-sensitive PKC-isoforms ␣, ␤, mediate(s) the effect of PMA on MRP2 loss from the pseudocanaliculi in HepG2 cells. After 10 hours of PMA treatment the canalicular index started to recover and reached control values after 24 to 36 hours (compare Fig. 3A ). This might be caused by reduced PKC expression 53 or because of a mechanism counteracting the PKC activity.
In rat liver and HepG2 cells it was shown that phorbol esters activate the MAP-kinases of the Erk-cascade upstream of MEK 21, 51 and induction of low-density lipoprotein receptor messenger RNA by the phorbol ester tetradecanoylphorbol-12-acetate was sensitive to PKC inhibition and simultaneously to MEK inhibition by PD098059. 51 Here we show that the loss of canalicular MRP2 induced by PMA is not mediated by Erks, because the effect is insensitive to PD098059 pretreatment. Therefore it can be concluded that the Erk pathway is probably not involved in the MRP2 dislocation downstream to PKC.
Zegers and Hoekstra 28 reported that treatment of HepG2 cells with PMA concentrations ranging from 5 to 20 nmol/L inhibited sphingolipid transport to the apical membrane while cell polarity was maintained. With PMA concentrations Ն100 nmol/L they observed a loss of cell polarity. This was accompanied by a redistribution of actin from the apical pole to the basolateral membrane, whereas apical marker proteins such as villin or P-gylcoproteins (detected by the C219 antibody) were lost from the apical membrane. Here we show that apical transporter proteins such as MRP2 are targeted to the basolateral membrane even at nondepolarizing PMA concentrations (0.5 nmol/L). The basolateral localization of MRP2 is shown by colocalization with the constitutively expressed MRP1, 40 with the basolateral fraction of dipeptidyl peptidase IV and with the sinusoidal bile salt transporter Ntcp of the rat, which was transfected into HepG2 cells. 36 The basolateral localization of apical transporter proteins has potential implication for the development of cholestasis because it might reverse the direction of biliary secretion. Interestingly, disruption of microtubules by colchicine induced a loss of MRP2-positive canaliculi but no basolateral MRP2 staining. This suggests, that PMA and colchicine activate different mechanisms of MRP2 dislocation from the canalicular membrane. This is supported by the finding, that colchicine, despite its own effect on canalicular MRP2, did not completely inhibit the appearance of MRP2 at the basolateral membrane induced by PMA (Fig. 7C) . Therefore, it can be concluded, that PMA-dependent reorganization of MRP2 occurs independent of microtubules. Nevertheless, our data show that microtubules are important for proper targeting of apical transporters. This is in line with findings by others, showing that transporter-bearing vesicles are associated with microtubules 49 and that stimulation of bile secretion is mediated by microtubule-dependent transporter insertion into the canalicular membrane. [54] [55] [56] [57] The observation, that MRP2 is shifted to intracellular sites after colchicine treatment suggests an inhibition of the insertion but not of the retrieval of MRP2 from the canalicular membrane. It might be speculated, that transporter insertion and retrieval are in a steady state, where the insertion depends on microtubules and the retrieval of another yet to be identified mechanism.
The source of basolateral MRP2 in PMA-treated cells is not clear yet. Preincubation for up to 4 hours with the protein synthesis inhibitor cycloheximide did not prevent the basolateral appearance of MRP2 induced by PMA. Therefore, it is unlikely that targeting of newly synthesized MRP2 from the Golgi apparatus to the basolateral membrane in response to PMA will explain our results. Another possibility is that MRP2 is released from the apical domain in PMA-treated cells by lateral membrane diffusion. This view is supported by the finding, that occludin, a protein of the tight junctional complex and a marker of paracellular permeability, disintegrates under PMA treatment. Therefore, loss of the tight junctional barrier between the basolateral and apical compartment might be the initial event in the observed dislocation of MRP2. This view is supported by findings that tight junctions disintegrate early after phorbolester treatment in polarized cell types. 58 Less likely, MRP2 might reach the basolateral membrane after retrieval from the canalicular membrane and reinsertion into the basolateral membrane, as a reversion of the indirect targeting.
Studies from the isolated perfused rat liver suggest that targeting of Mrp2 to the sinusoidal/basolateral membrane is possible in the intact organ thus confirming the results from experiments with HepG2 cells. It is likely that PKC stimulation by PMA is responsible for the strong cholestasis observed. So far, our results do not give information about the functional state of basolaterally localized Mrp2. Therefore, it cannot be concluded whether sinusoidal Mrp2 actively contributes to the observed cholestases.
This study shows that a canalicular ABC transporter can be (re)targeted to the basolateral membrane in response to PKC activation. The pathogenetic role of such a mechanism for cholestasis in vivo remains to be shown.
